Ling Fu Selected Research

anthrax toxin (anthrax lethal factor)

11/2016	[Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
1/2016	Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
1/2011	Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
10/2008	Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
3/2006	[Preliminary study of LFn-MAGE3 fusion protein expression and its biological function].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ling Fu Research Topics

Disease

43	Neoplasms (Cancer) 01/2023 - 10/2004
11	Anthrax 09/2019 - 09/2004
10	Infections 01/2023 - 01/2011
7	Breast Neoplasms (Breast Cancer) 12/2022 - 07/2007
6	Major Depressive Disorder (Major Depressive Disorders) 07/2023 - 01/2022
5	Pain (Aches) 03/2023 - 05/2014
5	Virus Diseases (Viral Diseases) 12/2020 - 03/2005
4	COVID-19 01/2022 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 11/2013 - 08/2007
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 04/2018
3	Rheumatoid Arthritis 10/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 04/2020 - 06/2012
3	Carcinoma (Carcinomatosis) 06/2018 - 11/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2018 - 12/2005
3	Carcinogenesis 12/2010 - 01/2006
3	Insulin Resistance 04/2008 - 08/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 01/2014
2	Edema (Dropsy) 03/2023 - 02/2016
2	Colonic Neoplasms (Colon Cancer) 12/2022 - 02/2015
2	Wounds and Injuries (Trauma) 01/2022 - 11/2016
2	Body Weight (Weight, Body) 06/2021 - 10/2017
2	Communicable Diseases (Infectious Diseases) 06/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 04/2020 - 06/2012
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 04/2014
2	Tetanus 04/2017 - 01/2016
2	Brucellosis (Malta Fever) 01/2017 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 07/2015 - 12/2012
2	Hepatocellular Carcinoma (Hepatoma) 04/2013 - 10/2004
2	Medulloblastoma 12/2012 - 09/2009
2	Plague (Bubonic Plague) 12/2009 - 02/2008
2	Lung Neoplasms (Lung Cancer) 01/2006 - 12/2005
2	Cataract (Cataracts) 03/2003 - 02/2002
1	Dizziness (Lightheadedness) 07/2023
1	Nausea 07/2023
1	Headache (Headaches) 07/2023
1	Yang Deficiency (Xu, Yang) 03/2023
1	Cardiotoxicity 03/2023

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 01/2020 - 09/2004
14	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2003
11	Biomarkers (Surrogate Marker)IBA 10/2023 - 12/2005
9	AntigensIBA 09/2019 - 08/2007
8	AntibodiesIBA 11/2016 - 09/2004
6	Messenger RNA (mRNA)IBA 12/2016 - 08/2009
5	Antidepressive Agents (Antidepressants)IBA 07/2023 - 01/2022
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2011
5	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 10/2004
5	anthrax toxin (anthrax lethal factor)IBA 11/2016 - 03/2006
4	Ketamine FDA LinkGeneric 07/2023 - 01/2022
4	Analgesics (Analgesic Drugs)IBA 03/2023 - 05/2014
4	EpitopesIBA 02/2014 - 03/2006
4	AdiponectinIBA 08/2009 - 08/2007
3	Phosphotransferases (Kinase)IBA 01/2022 - 01/2006
3	Monoclonal AntibodiesIBA 01/2020 - 11/2016
3	Anthrax Vaccines (Vaccines, Anthrax)IBA 09/2019 - 02/2014
3	Formaldehyde (Formol)FDA Link 06/2015 - 01/2014
3	ParaffinIBA 06/2015 - 01/2014
3	LigandsIBA 07/2014 - 01/2006
3	Adiponectin ReceptorsIBA 08/2009 - 08/2007
2	EsketamineIBA 07/2023 - 11/2022
2	AlkaloidsIBA 03/2023 - 01/2022
2	Reducing AgentsIBA 01/2022 - 07/2014
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 03/2005
2	Angiotensin-Converting Enzyme 2IBA 01/2022 - 12/2020
2	Sulfhydryl Compounds (Thiols)IBA 01/2022 - 11/2017
2	Complement System Proteins (Complement)IBA 01/2022 - 07/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2006
2	jaridon 6IBA 10/2021 - 11/2017
2	DiterpenesIBA 10/2021 - 11/2017
2	Tyrosine Kinase InhibitorsIBA 12/2018 - 04/2018
2	ErbB Receptors (EGF Receptor)IBA 12/2018 - 12/2005
2	LuciferasesIBA 04/2018 - 11/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 10/2013
2	Cyclin D1IBA 11/2017 - 10/2004
2	Combined VaccinesIBA 04/2017 - 12/2009
2	Neutralizing AntibodiesIBA 11/2016 - 10/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2016 - 01/2014
2	RNA (Ribonucleic Acid)IBA 01/2016 - 11/2014
2	Estrogen ReceptorsIBA 11/2014 - 01/2014
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 12/2005
2	Antiviral Agents (Antivirals)IBA 08/2014 - 03/2011
2	Virulence Factors (Pathogenicity Factors)IBA 02/2014 - 05/2013
2	Rituximab (Mabthera)FDA Link 01/2014 - 03/2012
2	tyrosine receptor (receptor, tyrosine)IBA 01/2013 - 01/2006
2	HhAntag691IBA 12/2012 - 09/2009
2	CatecholaminesIBA 08/2009 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 08/2007
2	Crystallins (Crystallin)IBA 03/2003 - 02/2002
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2023
1	LipopolysaccharidesIBA 03/2023
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2023
1	CarrageenanIBA 03/2023
1	fuzi drug herbalIBA 03/2023
1	Acetic Acid (Vinegar)FDA LinkGeneric 03/2023
1	GliotoxinIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	EstersIBA 01/2023

Therapy/Procedure

12	Therapeutics 05/2022 - 01/2006
3	Immunotherapy 11/2016 - 03/2006
3	Drug Therapy (Chemotherapy) 07/2015 - 12/2005
2	Precision Medicine 04/2020 - 01/2014